Telangana Health Minister urges pharma companies to provide CSR funds for govt hospitals

In a meeting with top pharma giants operating in the state, Telangana Health Minister Damodar Rajanarsimha on Monday urged them to provide Corporate Social Responsibility (CSR) funds for improvement of medical services and infrastructure at government hospitals like Osmania General Hospital and Gandhi Hospital. The minister asked the pharma majors to donate CSR funds for areas like power, laundry, bio-medical waste management, drinking water, education and health of the girl child.

The Minister says

Representatives of renowned pharma companies such as Mylan Laboratory, Gland Pharma Ltd, Natco Pharma, Bharat Biotech International Ltd, Dr Reddy’s Laboratory, Aurobindo Pharma Ltd, Hetero Drugs, Biological E, MSN Laboratory, Divis Laboratory, Virco Drugs and Granules India Ltd, attended the meeting with the minister hosted at the secretariat.

While talking to the representatives, Minister Rajanarsimha spoke about the significance of Osmania General Hospital and Gandhi Hospital. He also highlighted that CSR funds can be utilized to enhance facility in areas such as patient care, sanitation, diet, staff education and medical services.

Role of pharma majors

The CSR heads from the 12 leading pharma companies, who were present at the meeting, will be visiting the above hospitals to assess priority areas, following which a technical report will be prepared on the basis of the inputs shared by them. Superintendents of both the hospitals have been asked to submit proposals highlighting the necessary infrastructure and human resource requirements.

“A technical report will be submitted on the priority issues during the field visit. He directed superintendents of OGH and Gandhi Hospitals to submit the proposals for the creation of infrastructure and resources for improving patient services,” according to an official statement released by the minister’s office.